Showing results (3821-3830 of 6,795) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|January 25, 2000
Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapiesP C Langley, G A Richwald, M H Smith
Clinical Therapeutics|June 11, 1999
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladderM M Goldenberg
Clinical Therapeutics|June 11, 1999
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertralineH Croft, E Settle, T Houser, et al.
Clinical Therapeutics|June 11, 1999
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infectionsB A Lipsky, B Miller, R Schwartz, et al.
Clinical Therapeutics|June 11, 1999
Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidityM Sajatovic, S DiGiovanni, M Fuller, et al.
Clinical Therapeutics|June 11, 1999
Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savingsA Marchetti, H Lau, R Magar, et al.
Clinical Therapeutics|August 10, 1999
Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's diseaseJ F Mouser, J S Hyams
Clinical Therapeutics|August 10, 1999
Clinical and economic impact of newer versus older antipsychotic medications in a community mental health centerP M Galvin, L D Knezek, A J Rush, et al.
Clinical Therapeutics|September 15, 1999
Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental painK Gottesdiener, D R Mehlisch, M Huntington, et al.
Clinical Therapeutics|September 15, 1999
Procedure costs and outcomes associated with pharmacologic management of peripheral arterial disease in the Department of DefenseW M Zachry, J P Wilson, K A Lawson, et al.
Pageof 680